Archford Capital Strategies’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-50
| Closed | -$12K | – | 250 |
|
|
2019
Q2 | $12K | Hold |
50
| – | – | ﹤0.01% | 389 |
|
|
2019
Q1 | $12K | Hold |
50
| – | – | ﹤0.01% | 375 |
|
|
2018
Q4 | $15K | Hold |
50
| – | – | 0.01% | 344 |
|
|
2018
Q3 | $18K | Hold |
50
| – | – | 0.01% | 372 |
|
|
2018
Q2 | $15K | Hold |
50
| – | – | 0.01% | 392 |
|
|
2018
Q1 | $16K | Buy |
+50
| New | +$16K | 0.01% | 299 |
|
|
2017
Q2 | – | Sell |
-50
| Closed | -$14K | – | 245 |
|
|
2017
Q1 | $14K | Sell |
50
-4
| -7% | -$1.12K | 0.01% | 401 |
|
|
2016
Q4 | $15K | Hold |
54
| – | – | 0.01% | 343 |
|
|
2016
Q3 | $16K | Sell |
54
-20
| -27% | -$5.93K | 0.01% | 339 |
|
|
2016
Q2 | $18K | Buy |
+74
| New | +$18K | 0.01% | 338 |
|
|
2016
Q1 | – | Sell |
-74
| Closed | -$23K | – | 225 |
|
|
2015
Q4 | $23K | Buy |
74
+4
| +6% | +$1.24K | 0.01% | 355 |
|
|
2015
Q3 | $21K | Buy |
70
+14
| +25% | +$4.2K | 0.02% | 269 |
|
|
2015
Q2 | $22K | Buy |
56
+54
| +2,700% | +$21.2K | 0.02% | 268 |
|
|
2015
Q1 | $844 | Buy |
+2
| New | +$844 | ﹤0.01% | 649 |
|